Tango Therapeutics Inc
TNGX
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.55B
Close$
$-14.64
168.2% downside
Current Fair Value
168.2% downsideOvervalued by 168.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.55 Billion |
|---|---|
| Enterprise Value | $2.43 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.87 |
| Beta | 1.22 |
| Outstanding Shares | 143,576,292 |
Return
| Return on Equity | -27.39% |
|---|---|
| Return on Assets | -24.61% |
| Return on Invested Capital | -27.06% |
Valuation & Multiples
| P/E Ratio | -29.43 |
|---|---|
| PEG | -208.15 |
| Price to Sales | - |
| Price to Book Ratio | 10.74 |
| Enterprise Value to Revenue | 42.61 |
| Enterprise Value to EBIT | -21.29 |
| Enterprise Value to Net Income | -23 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$578,091
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
$1.56 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.9866▲ 43.23% |
|---|---|
| Total Calls | 89,600▲ 67.79% |
| Total Puts | 88,400▲ 198.65% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 155.17%▼ 0.18% |
|---|---|
| Total Invested | $3.77B▲ 146.97% |
| Investors Holding | 198▲ 26.00% |
ESG Score
No data
About Tango Therapeutics Inc
4 employees